CD8A and neoplasm: Immunotherapy in the EMT6 tumor model led to increased induction of direct killing (by CD8+ effector cells) using splenocytes from treated mice, along with increased cytokine production in vitro-both effects were attenuated in mice receiving anti-CD4 treatment in vivo (Figure S2).